Irhythm Stock Analysis

IRTC -  USA Stock  

USD 51.18  1.43  2.72%

The big decline in price over the last few months for Irhythm Technologiesmay raise some interest from investors. The stock closed today at a share price of 51.18 on very low momentum in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in June. However, diversifying your holdings with Irhythm Technologies or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.49. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Irhythm Technologies partners.
Please see Risk vs Return Analysis.

Search Stock Analysis 

 
Refresh
The Irhythm Technologies stock analysis report makes it easy to digest most publicly released information about Irhythm Technologies and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Irhythm Stock analysis module also helps to analyze the Irhythm Technologies price relationship with some important fundamental indicators such as market cap and management efficiency.

Irhythm Stock Analysis Notes

About 110.0% of the company shares are owned by institutional investors. The book value of Irhythm Technologies was currently reported as 11.77. The company recorded a loss per share of 1.58. Irhythm Technologies had not issued any dividends in recent years. iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for patients at risk for arrhythmias in the United States. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Irhythm Technologies operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1157 people. To learn more about Irhythm Technologies call Kevin King at 415 632-5700 or check out www.iRhythmTech.com.

Irhythm Technologies Quarterly Cost of Revenue

23.46 MillionShare

Irhythm Technologies Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Irhythm Technologies' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Irhythm Technologies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Irhythm Technologies generates negative expected return over the last 90 days
Irhythm Technologies has high historical volatility and very poor performance
The company reported the previous year's revenue of 275.94 M. Net Loss for the year was (62.54 M) with profit before overhead, payroll, taxes, and interest of 194.89 M.
Irhythm Technologies currently holds about 262.29 M in cash with (33.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.95.
Latest headline from www.equities.com: iRhythm Technologies Inc gains 0.87 percent for July 20 - Equities.com

Irhythm Technologies Upcoming and Recent Events

Earnings reports are used by Irhythm Technologies to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Irhythm Technologies previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report5th of August 2021
Next Earnings Report4th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Irhythm Largest EPS Surprises

Earnings surprises can significantly impact Irhythm Technologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2016-12-05
2016-09-30-0.2102-0.1840.026212 
2017-11-01
2017-09-30-0.3233-0.290.033310 
2021-05-06
2021-03-31-0.8523-0.95-0.097711 
View All Earnings Estimates

Irhythm Technologies SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Irhythm Technologies prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Irhythm Technologies investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Irhythm Technologies specific information freely available to individual and institutional investors to make a timely investment decision.
9th of July 2021
Unclassified Corporate Event
View
6th of July 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
21st of June 2021
Submission of Matters to a Vote of Security Holders
View
1st of June 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
6th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
12th of April 2021
Regulation FD Disclosure. Results of Operations and Financial Condition
View
25th of February 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
16th of February 2021
Unclassified Corporate Event
View

Irhythm Technologies Thematic Classifications

In addition to having Irhythm Technologies stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

Irhythm Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Irhythm Technologies's market, we take the total number of its shares issued and multiply it by Irhythm Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Irhythm Profitablity

Irhythm Technologies' profitability indicators refer to fundamental financial ratios that showcase Irhythm Technologies' ability to generate income relative to its revenue or operating costs. If, let's say, Irhythm Technologies is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Irhythm Technologies' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Irhythm Technologies' profitability requires more research than a typical breakdown of Irhythm Technologies' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (22.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (22.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.22.
Last ReportedProjected for 2021
Return on Investment(16.03) (17.29) 
Return on Average Assets(0.11) (0.12) 
Return on Average Equity(0.19) (0.20) 
Return on Invested Capital(0.11) (0.12) 
Return on Sales(0.16) (0.17) 

Management Efficiency

The entity has return on total asset (ROA) of (10.17) % which means that it has lost $10.17 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (28.79) %, meaning that it created substantial loss on money invested by shareholders. Irhythm Technologies management efficiency ratios could be used to measure how well irhythm technologies manages its routine affairs as well as how well it operates its assets and liabilities. As of July 23, 2021, Return on Investment is expected to decline to -17.29. In addition to that, Return on Average Assets is expected to decline to -0.12. Irhythm Technologies Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 511.74 Million. The current year Current Assets is expected to grow to about 407.7 M, whereas Goodwill and Intangible Assets are forecasted to decline to about 771.3 K.
Last ReportedProjected for 2021
Book Value per Share 12.31  13.28 
Enterprise Value over EBIT(163.00) (167.29) 
Enterprise Value over EBITDA(235.97) (242.18) 
Price to Book Value 20.05  20.86 
Tangible Assets Book Value per Share 18.41  16.16 
Enterprise Value6.9 B7.4 B
Tangible Asset Value510.9 M551.2 M

Technical Drivers

As of the 23rd of July, Irhythm Technologies retains the risk adjusted performance of (0.13), and Market Risk Adjusted Performance of (1.91). Irhythm Technologies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Irhythm Technologies, which can be compared to its competitors. Please check out Irhythm Technologies variance, as well as the relationship between the maximum drawdown and semi variance to decide if Irhythm Technologies is priced fairly, providing market reflects its last-minute price of 51.18 per share. Given that Irhythm Technologies has jensen alpha of (0.68), we strongly advise you to confirm Irhythm Technologies's regular market performance to make sure the company can sustain itself at a future point.

Irhythm Technologies Price Movement Analysis

The output start index for this execution was nine with a total number of output elements of fifty-two. The Exponential Moving Average is calculated by weighting recent values of Irhythm Technologies more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Irhythm Technologies Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Irhythm Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on Irhythm Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Irhythm Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Wilson Daniel G over two weeks ago via Macroaxis 
Acquisition by Wilson Daniel G of 13227 shares of Irhythm Technologies subject to Rule 16b-3
Bairey Merz Cathleen Noel over a month ago via Macroaxis 
Acquisition by Bairey Merz Cathleen Noel of 2226 shares of Irhythm Technologies subject to Rule 16b-3
Wilson Daniel G over two months ago via Macroaxis 
Irhythm Technologies exotic insider transaction detected
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3
Kevin King over three months ago via Macroaxis 
Exercise or conversion by Kevin King of 2836 shares of Irhythm Technologies subject to Rule 16b-3

Irhythm Technologies Technical and Predictive Indicators

Irhythm Technologies Forecast Models

Irhythm Technologies time-series forecasting models is one of many Irhythm Technologies' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Irhythm Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Irhythm Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Irhythm Technologies stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Irhythm shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Irhythm Technologies. By using and applying Irhythm Stock analysis, traders can create a robust methodology for identifying Irhythm entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin(16.47) (17.77) 
EBITDA Margin(0.11) (0.12) 
Gross Margin 0.73  0.78 
Profit Margin(0.17) (0.18) 
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for patients at risk for arrhythmias in the United States. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Irhythm Technologies operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1157 people.

Current Irhythm Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Irhythm analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Irhythm analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
133.71Hold7Odds
Irhythm Technologies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Irhythm analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Irhythm stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Irhythm Technologies, talking to its executives and customers, or listening to Irhythm conference calls.
Irhythm Analyst Advice Details

Irhythm Stock Analysis Indicators

Irhythm Technologies stock analysis indicators help investors evaluate how Irhythm Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Irhythm Technologies shares will generate the highest return on investment. By understating and applying Irhythm Technologies stock analysis, traders can identify Irhythm Technologies position entry and exit signals to maximize returns.
Quick Ratio5.43
Fifty Two Week Low49.85
Revenue Growth17.00%
Shares Short Prior Month2.39M
Average Daily Volume Last 10 Day552.55k
Average Daily Volume In Three Month643.08k
Shares Percent Shares Out7.73%
Gross Margins71.85%
Short Percent Of Float9.64%
Forward Price Earnings-19.19
Float Shares28.95M
Fifty Two Week High286.19
Enterprise Value To Ebitda-31.56
Fifty Day Average62.87
Two Hundred Day Average123.64
Enterprise Value To Revenue6.24
Please see Risk vs Return Analysis. Note that the Irhythm Technologies information on this page should be used as a complementary analysis to other Irhythm Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Irhythm Stock analysis

When running Irhythm Technologies price analysis, check to measure Irhythm Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Irhythm Technologies is operating at the current time. Most of Irhythm Technologies' value examination focuses on studying past and present price action to predict the probability of Irhythm Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Irhythm Technologies' price. Additionally, you may evaluate how the addition of Irhythm Technologies to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Irhythm Technologies is measured differently than its book value, which is the value of Irhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Irhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is Irhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Irhythm Technologies' market value can be influenced by many factors that don't directly affect Irhythm Technologies underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Irhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Irhythm Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Irhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.